YBX1 and breast carcinoma: Previous studies from many laboratories have consistently shown that the enhanced expression of YBX1 protein or mRNA in mammary tumors is significantly correlated with malignant progression or poor outcomes in patients with breast cancer [21, 23, 27, 28].